MedTrace Logo

The German ADPKD Tolvaptan Treatment Registry

NCT02497521 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 2000

Last updated 2026-04-30

No results posted yet for this study

Summary

The German ADPKD Tolvaptan Treatment Registry is a prospective, observational, multicentric study of patients suffering from ADPKD that are considered for tolvaptan treatment. All ADPKD patients that are evaluated for treatment indication, or that are planned to be treated with tolvaptan, or that are already treated with tolvaptan are eligible. This registry is designed to provide "real-world" data on treatment management of patients with ADPKD.

Conditions

  • ADPKD (Autosomal Dominant Polycystic Kidney Disease)

Sponsors & Collaborators

  • University of Cologne

    lead OTHER

Principal Investigators

  • Thomas Benzing, MD, Prof. · University Hospital of Cologne

  • Roman-Ulrich Müller, MD, Prof. · University Hospital Cologne

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2027-12-31
Completion
2027-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02497521 on ClinicalTrials.gov